title: Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Hunger
authors.forename: Thomas
authors.initials: T
authors.lastname: Hunziker
authors.forename: Urs
authors.initials: U
authors.lastname: Buettiker
authors.forename: Lasse R
authors.initials: LR
authors.lastname: Braathen
authors.forename: Nikhil
authors.initials: N
authors.lastname: Yawalkar
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004008:Diclofenac / Q000009:adverse effects; D005260:Female; D006801:Humans; D000069285:Infliximab; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012867:Skin / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D004008:Diclofenac; D000069285:Infliximab